ACTA is a leading Northern California manufacturer of herbal based nutraceuticals.
ACTA was approached by a pre-IPO rollup sponsor to be acquired concurrently with the initial public offering. Because of its size, ACTA was the platform company around which the deal was built. ACTA’s financial contribution to the whole ensured the financial strength required to be a successful IPO.
Brereton, Hanley and Company negotiated an exceptional high equity position in the combined company for ACTA as well as the highest “off-the-table” cash component of any seller in the rollup. The S1 was filed with the SEC, however, due to unfavorable market conditions, the IPO was withdrawn and the deal did not close.